Table 2.
Comparison of general data between the two groups
| Item | Single treatment group | Combined treatment group | T/χ2 value | P value |
|---|---|---|---|---|
| Gender | 0.521 | 0.470 | ||
| Male | 21 | 18 | ||
| Female | 14 | 17 | ||
| Age (years) | 56.7±7.2 | 57.3±6.9 | 0.774 | 0.442 |
| Type of disease | 1.048 | 0.592 | ||
| Leukemia | 10 | 11 | ||
| Lymphoma | 16 | 12 | ||
| Myeloma | 9 | 12 | ||
| Chemotherapy course | 2.083 | 0.353 | ||
| 1-3 | 8 | 11 | ||
| 4-6 | 15 | 10 | ||
| >6 | 10 | 14 | ||
| BMI (kg/m2) | 24.8±1.8 | 25.1±1.9 | 0.773 | 0.492 |
| Chemotherapy plans | 0.393 | 0.822 | ||
| DA | 7 | 9 | ||
| R-CHOP | 15 | 13 | ||
| VAD | 13 | 13 |
Note: DA: Daunorubicin + Cytarabine; R-CHOP: Rituxima + Cyclophosphamide + Doxorubicin + Vincristine + Prednisone; VAD: Vincristine + Doxorubicin + Dexamethasone. t denotes for independent sample t test, and χ2 for Chi square test. BMI: body mass index.